Evidence map›Paper›PMID 42469933›Full record

ArticleJournal of pharmaceutical health care and sciences2026

Correction: Association between the incidence of infusion-related reactions by obinutuzumab and the dose of corticosteroid as premedication: a multicenter retrospective cohort study.

Tatsuya Ohtsubo, Kazuhiro Yamamoto, Saori Matumoto, Kaori Ito, Yuzuka Sasa, Kosuke Tomishima, Satoshi Dote, Katsuya Makihara, Yoshinori Wakasugi, Tsutomu Mitsuie and 6 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of pharmaceutical health care and sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Tatsuya OhtsuboDepartment of Pharmacy, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan. ohtsubot35@gmail.com.
Kazuhiro YamamotoDepartment of Integrated Clinical and Basic Pharmaceutical Sciences, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Saori MatumotoDepartment of Pharmacy, Japanese Red Cross Osaka Hospital, Osaka, Japan.
Kaori ItoFaculty of Pharmacy, Meijo University, Nagoya, Japan.
Yuzuka SasaDepartment of Pharmacy, Kindai University Hospital, Sakai, Japan.
Kosuke TomishimaDepartment of Pharmacy, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
Satoshi DoteDepartment of Pharmacy, Kyoto-Katsura Hospital, Kyoto, Japan.
Katsuya MakiharaDepartment of Pharmacy, Yodogawa Christian Hospital, Osaka, Japan.
Yoshinori WakasugiDepartment of Pharmacy, Shiga University of Medical Science Hospital, Otsu, Japan.
Tsutomu MitsuieDepartment of Pharmacy, Japanese Red Cross Otsu Hospital, Otsu, Japan.
Kouhei YamagiwaDepartment of Pharmacy, Saiseikai Shiga Hospital, Ritto, Japan.
Kazuo SatoDepartment of Pharmacy, Japan Baptist Hospital, Kyoto, Japan.
Hiroki HasegawaDepartment of Pharmacy, Rakuwakai Otowa Hospital, Kyoto, Japan.
Nobuhiko UoshimaDepartment of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.
Yumi KitahiroDepartment of Pharmacy, Kobe University Hospital, Kobe, Japan.
Kanji TomoganeDepartment of Pharmacy, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42469933
PMCPMC13379959

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.